The Joint Commission’s brain tumor care certification is part of the organization’s broader disease-specific-care certification program, which launched in 2002. Under it, hospitals and health systems can apply for certification across multiple conditions or chronic diseases. The brain tumor certification falls under its hematology/oncology certification category.
Recipients must meet standards and adhere to criteria related to each certification and also undergo an on-site review, which evaluates the organization’s clinical outcomes, evidence-based guidelines within daily practices, performance metrics and care improvements, if leaders are involved in improving quality of care, and how patients are educated and prepared to discharge.
The seven hospitals certified in brain tumor care are:
- Chippenham and Johnston-Willis Hospital, Richmond, Va.
- Hackensack (N.J.) University Medical Center Hackensack
- Jewish Hospital, Cincinnati
- Pitt County Memorial Hospital, Greenville, N.C.
- Santa Barbara (Calif.) Cottage Hospital
- St. Vincent Hospital and Health Care Services, Indianapolis
- Texas Health Harris Methodist Hospital – Fort Worth
Disease-specific certifications are granted for a two-year period. Following that, a program must regularly re-apply and re-submit data for evaluation to The Joint Commission.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
